{"id":376052,"date":"2025-11-13T13:52:33","date_gmt":"2025-11-13T13:52:33","guid":{"rendered":"https:\/\/www.europesays.com\/us\/376052\/"},"modified":"2025-11-13T13:52:33","modified_gmt":"2025-11-13T13:52:33","slug":"glac-biotech-wins-double-honors-at-the-isee-global-innovation-awards-lactobacillus-plantarum-pl-02-sets-a-new-benchmark-for-functional-probiotics","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/376052\/","title":{"rendered":"GLAC Biotech Wins Double Honors at the iSEE Global Innovation Awards Lactobacillus plantarum PL-02 Sets a New Benchmark for Functional Probiotics"},"content":{"rendered":"

TAIPEI, Nov. 11, 2025 \/PRNewswire\/ \u2014 GLAC Biotech, a leading innovator in probiotics and postbiotics research, proudly announces another milestone on the global stage. Its flagship strain, Lactobacillus plantarum PL-02<\/b>, has been honored with two major awards<\/b> at the 7th iSEE Global Innovation Awards<\/b>, recognizing its outstanding scientific validation and breakthrough applications in both brain health and sports nutrition.<\/p>\n

\"GLAC <\/a>
GLAC Biotech Triumphs with Double Honors at the iSEE Global Innovation Awards \u2014 PL-02 Pioneers the Future of Brain and Sports Health.<\/p>\n

Scientifically Proven: The Power of PL-02<\/b><\/p>\n

Derived from the microbiome of an Olympic gold medalist, PL-02<\/b> represents the fusion of athletic vitality and advanced scientific research. Extensive studies have demonstrated PL-02\u2019s exceptional acid and bile tolerance, intestinal colonization ability<\/b>, and its multi-faceted benefits for energy metabolism, physical performance, and gut-brain health<\/b>.<\/p>\n

Through years of rigorous R&D, GLAC Biotech has established PL-02 as a next-generation functional probiotic<\/b>, setting new standards in evidence-based innovation.<\/p>\n

Double Awards for Scientific Excellence<\/b><\/p>\n

Two functional probiotic ingredients developed from PL-02 stood out among global competitors to win dual recognition at the iSEE Awards:<\/p>\n

PRONULIFE\u00ae IntBrain<\/b>\u00a0\u2014 A brain-health probiotic that supports focus, cognitive performance, and emotional balance through gut-brain axis modulation.<\/p>\n

PRONULIFE\u00ae Effenergy<\/b>\u00a0\u2014 A sports-performance probiotic that enhances endurance, accelerates recovery, and optimizes energy utilization.<\/p>\n

These twin honors mark a major international endorsement of PL-02\u2019s proven efficacy and underline GLAC Biotech\u2019s global leadership in probiotic innovation.<\/p>\n

iSEE Global Recognition \u2014 Taiwan\u2019s Scientific Pride<\/b><\/p>\n

Known as the \u201cOscars of the Health Industry,\u201d the iSEE Global Innovation Awards celebrate products that combine innovation, efficacy, and scientific rigor.PL-02\u2019s double victory not only highlights its strong clinical foundation but also positions Taiwan\u2019s biotech research at the forefront of the global probiotic industry.<\/b>\u201cPL-02 is more than a probiotic strain \u2014 it embodies the spirit of scientific excellence and human performance,<\/b>\u201d said GLAC Biotech.
\u201cThis recognition affirms our long-term commitment to clinical validation and global collaboration in functional probiotics.\u201d<\/p>\n

Looking Ahead: Expanding the Frontier of Functional Health<\/b><\/p>\n

GLAC Biotech will continue advancing research on PL-02 to expand its applications in brain health, sports performance, and energy metabolism<\/b>, while fostering global partnerships to bring Taiwan-origin probiotic innovations to the world.<\/p>\n

Event Preview\uff5cNatural Extracts & Health Ingredients Exhibition (FIC-Health 2025) & the 24th National Food Additives and Ingredients Exhibition<\/p>\n

Date: November 26\u201328, 2025
Booth:\u00a010B58
Seminar:\u00a0November 27, 11:00 AM \uff5c\u00a0Meeting Room 4
Topic:\u00a0\u201cUnlocking the Mind-Body Frontier \u2014 PL-02 Probiotic, a New Choice for Cognitive and Athletic Performance.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"TAIPEI, Nov. 11, 2025 \/PRNewswire\/ \u2014 GLAC Biotech, a leading innovator in probiotics and postbiotics research, proudly announces…\n","protected":false},"author":3,"featured_media":376053,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[210,1182,67,132,68],"class_list":{"0":"post-376052","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nutrition","8":"tag-health","9":"tag-nutrition","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115542724186937582","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/376052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=376052"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/376052\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/376053"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=376052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=376052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=376052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}